Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia

Experimental Neurology

Volumn 146, Issue 2, 1997, Pages 567-569

  Matsushita, Sachio ^a   Arai, Hiroyuki ^b   Muramatsu, Taro ^a   Makimoto, Kiyoko ^c   Nakagawa, Takuma ^b   Sasaki, Hidetada ^b   Higuchi, Susumu ^a  

^a KURIHAMA NATIONAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GENE PRODUCT; PRESENILIN 1;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL;

EID: 0031213987     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6558     Document Type: Article

References (13)

1. 1. Folstein, M., S. Folstein, and P. R. McHugh. 1975. Mini-mental state: A practical method for grading the cognitive state of patients for the clinicians. J. Psychiatr. Res. 12: 189-198.
2. 2. Higuchi, S., T. Muramatsu, S. Matsushita, H. Arai, and H. Sasaki. 1996. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347: 1186.
3. 3. Kehoe, P., J. Williams, S. Lovestone, G. Wilcock, M. J. Owen, and the UK Alzheimer's Disease Collaborative Group. 1996. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347: 1185.
4. 4. Kirkwood, B. 1994. Essentials of Medical Statistics, Blackwell Sci., London.
5. 5. Kleinbaum, D. G., L. L. Kupper, and H. Morgenstern. 1982. Lifetime Learning Publications, Belmont, CA.
6. 6. Mann, D. M., T. Iwatsubo, N. J. Cairns, P. L. Lantos, D. Nochlin, S. M. Sumi, T. D. Bird, P. Poorkaj, J. Hardy, M. Hutton, G. Prihar, R. Crook, M. N. Rossor, and M. Haltia. 1996. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Abeta42(43). Ann. Neurol. 40(2): 149-156.
7. 246) familial Alzheimer's cells. NeuroReport 7: 297-301.
8. 8. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 34: 939-944.
9. 9. Roman, G. C., T. K. Tatemichi, T. Erkinjuntti, J. L. Cummings, J. C. Masdeu, J. H. Garcia, L. Amaducci, J. M. Orgogozo, A. Brun, A. Hofman, D. M. Moody, M. D. O'Brien, T. Yamaguchi, J. Grafman, B. P. Drayer, D. A. Bennett, M. Fisher, J. Ogata, E. Kokmen, F. Bermejo, P. A. Wolf, P. B. Gorelick, K. L. Bick, A. K. Pajeau, M. A. Bell, C. DeCarli, A. Culebras, A. D. Korczyn, J. Bogousslavsky, A. Hartmann, and P. Scheinberg. 1993. Vascular dementia: Diagnostic criteria for research studies. Neurology 43: 250-260.
10. 10. Scheuner, D., C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, and S. Younkin. 1996. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2: 864-870.
11. 11. Scott, W. K., J. H. Growdon, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance. 1996. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347: 1187.
12. 12. Wenham, P. R., W. H. Price, and G. Blundell. 1991. Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158-1159.
13. 13. Wragg, M., M. Hutton, C. Talbot, and the Alzheimer's Disease Collaborative Group. 1996. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347: 509-512.